Swiss Basic Materials Stock News

Novartis (SWX:NOVN) posted strong earnings for the period, with profits rising 22.4% year over year, well above its 5-year average annual growth of just 0.09%. Net profit margin climbed to 25.5% from 23.6% a year ago, signaling improved profitability. While revenue growth is forecast at 3.4% per year, trailing the Swiss market average of 4%, ongoing momentum and a current share price of CHF98.5, which is below estimated fair value, give investors plenty to analyze as they look ahead. See our...

Harrington Process Solutions recently announced an expansion of its partnership with Georg Fischer, granting Harrington full-line access to Georg Fischer's flow control products for corrosive waste and high purity applications across the United States. This expanded collaboration strengthens both companies' capabilities and market reach, particularly in mission-critical industries such as data centers, life sciences, and biopharmaceuticals. We'll examine how broader national distribution of...

Landis+Gyr Group (SWX:LAND) remains unprofitable, but it has reduced its losses by an average of 25.2% per year over the last five years. Looking ahead, the company is forecast to become profitable within three years, with earnings expected to surge by 93.67% per year, even as revenue is set to decline at a rate of 3.3% annually. For investors, the standout is the aggressive earnings growth on the horizon, positioning LAND as a turnaround story despite the top-line headwind. See our full...

Key Insights The considerable ownership by individual investors in Swissquote Group Holding indicates that they...

Logitech International (SWX:LOGN) has seen its earnings decline by 8.5% per year over the past five years, with its net profit margin falling to 14.1% from last year's 15.6%. Looking ahead, analysts forecast earnings to grow at a modest 4.2% annually, which is below the Swiss market's projected 10.7% growth rate. Despite the tempered profit outlook and tightening margins, revenue is expected to rise at 5.3% per year, outpacing the wider market, and the company currently trades at a discount...

WISeSat.Space, a subsidiary of WISeKey International Holding, recently signed a Memorandum of Understanding with South Korea's INNOSPACE to collaborate on deploying next-generation, quantum-resistant satellites using the HANBIT-SERIES launch vehicles. This partnership expands WISeSat.Space's global reach by leveraging South Korea’s growing space sector and supports secure Internet of Things and cybersecurity applications through diversified launch options. We'll explore how leveraging...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

There wouldn't be many who think Georg Fischer AG's ( VTX:GF ) price-to-earnings (or "P/E") ratio of 19.5x is worth a...

While stock picking isn't easy, for those willing to persist and learn, it is possible to buy shares in great...

Shareholders might have noticed that Schindler Holding AG ( VTX:SCHN ) filed its third-quarter result this time last...

When close to half the companies in the Luxury industry in Switzerland have price-to-sales ratios (or "P/S") below...

Key Insights The considerable ownership by retail investors in Avolta indicates that they collectively have a greater...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

There wouldn't be many who think Burckhardt Compression Holding AG's ( VTX:BCHN ) price-to-earnings (or "P/E") ratio of...

Sika (SWX:SIKA) delivered earnings forecast to grow at 10% per year, with revenue set to rise by 4.7% annually, outpacing the broader Swiss market’s projected 4% growth rate. Over the past five years, earnings have climbed by 6.9% each year, and the company has maintained a net profit margin of 10.5%, matching the prior period. These numbers, paired with Sika’s high-quality earnings profile and only minor risk concerns, provide investors with a constructive outlook anchored by continued...

When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 19x, you may consider...

Kuehne + Nagel International (SWX:KNIN) reported a net profit margin of 4.5%, down from 5% the previous year. This marks a modest uptick in earnings with 1.3% growth after several years of decline. While current profitability has improved, the company’s shares are trading at a Price-To-Earnings ratio of 16.1x, which represents a premium to industry peers but remains below intrinsic value as indicated by discounted cash flow estimates. Soft margins, ongoing profit growth, and concerns about...

Tecan Group AG ( VTX:TECN ), is not the largest company out there, but it saw significant share price movement during...

TX Group AG's ( VTX:TXGN ) price-to-sales (or "P/S") ratio of 2.3x may not look like an appealing investment...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Logitech International (SWX:LOGN) shares have seen steady movement over the past month, with the stock currently trading near CHF 87. Despite recent market shifts, investors remain focused on the company’s financial fundamentals and growth trends. See our latest analysis for Logitech International. Logitech’s share price has climbed 13.6% over the past 90 days, adding to an impressive 23.6% total shareholder return for the past year. Momentum has clearly been building, supported by solid...

ARYZTA AG’s Board of Directors recently announced that Michael Schai has stepped down as CEO with immediate effect, with Chairman Urs Jordi appointed as interim CEO, while also confirming unchanged organic growth guidance for 2025. This simultaneous leadership transition and reaffirmation of earnings guidance highlights the company’s intent to maintain stability during executive changes and ongoing strategy execution. We’ll now explore how the immediate CEO transition, alongside steady...

Kuros Biosciences recently raised its 2025 annual guidance, reporting a 77% increase in revenue for the first nine months and announcing new product milestones, including FDA clearance and commercial launch of the MagnetOs MIS Delivery System in the U.S. as well as regulatory approval in Saudi Arabia. These achievements highlight the company's accelerated international expansion and increasing commercial traction in both the U.S. and MENA regions. We'll explore how Kuros Biosciences' rapid...